A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer

TitleA hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer
Publication TypeJournal Article
Year of Publication2017
AuthorsVogus DR, Evans MA, Pusuluri A, Barajas A, Zhang M, Krishnan V, Nowak M, Menegatti S, Helgeson ME, Squires TM, Mitragotri S
JournalJournal of Controlled Release
ISSN0168-3659
KeywordsDoxorubcin
URLhttp://www.sciencedirect.com/science/article/pii/S0168365917307836
DOI10.1016/j.jconrel.2017.08.016